发明名称 Use of isolated placental intermediate natural killer cells in the manufacture of a composition for treating viral infection
摘要 Provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising contacting the tumor cells, or administering to the individual, placental perfusate, placental perfusate cells, or natural killer cells, e.g., placenta-derived intermediate natural killer cells, with an immunomodulatory compound or thalidomide.
申请公布号 IL215228(A) 申请公布日期 2016.11.30
申请号 IL20110215228 申请日期 2011.09.19
申请人 ANTHROGENESIS CORPORATION 发明人
分类号 A61K;A61P;C12N 主分类号 A61K
代理机构 代理人
主权项
地址